批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/06/10 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/06/10 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/06/10 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/06/10 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/12/13 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/09/27 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/12 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/27 |
ORIG-2(原始申请) |
Tentative Approval |
Not Applicable |
|
|
|
2013/02/27 |
ORIG-1(原始申请) |
Approval |
Not Applicable |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;150MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020758 |
002 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
Yes |
Yes |
AB |
1997/09/30
|
SANOFI AVENTIS US |
077369 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
077446 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
202414 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
203500 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
090351 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
091370 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
203630 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
201524 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
203072 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
207896 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
207018 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;150MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020758 |
002 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
Yes |
Yes |
AB |
1997/09/30
|
SANOFI AVENTIS US |
077369 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
077446 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
202414 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
203500 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
090351 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
091370 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
203630 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
201524 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
203072 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
207896 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
207018 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;300MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020758 |
003 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
Yes |
Yes |
AB |
1998/08/31
|
SANOFI AVENTIS US |
077369 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
077446 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
202414 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
203500 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
090351 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
091370 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
203630 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
201524 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
203072 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
207896 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
207018 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;300MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020758 |
003 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
Yes |
Yes |
AB |
1998/08/31
|
SANOFI AVENTIS US |
077369 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
077446 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
202414 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
203500 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
090351 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
091370 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
203630 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
201524 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
203072 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
207896 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
207018 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |